Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Research Support, Non-U.S. Gov't"
topic_facet:"YL5FZ2Y5U1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22YL5FZ2Y5U1%22&lookfor=%221468-2060%22&type=ISN
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22YL5FZ2Y5U1%22&lookfor=%221468-2060%22&type=ISN
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22YL5FZ2Y5U1%22&lookfor=%221468-2060%22&type=ISN
PubPharm (360)
1
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs : two phase 3 randomised trials (contRAst 1 and contRAst 2)
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Fleischmann, R.
|
van der Heijde, D.
|
Strand, V.
| +19
Wird geladen...
2
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies : a phase III randomised trial (contRAst 3)
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Taylor, P.
|
Weinblatt, M.
|
McInnes, I.
| +18
Wird geladen...
3
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Østergaard, M.
|
van Vollenhoven, R.
|
Rudin, A.
| +96
Wird geladen...
4
Safety profile of upadacitinib in patients at risk of cardiovascular disease : integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Fleischmann, R.
|
Curtis, J.
|
Charles-Schoeman, C.
| +8
Wird geladen...
5
Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate : a randomised, double-blind, phase IIa trial
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Takeuchi, T.
|
Tanaka, S.
|
Murata, M.
| +1
Wird geladen...
6
JAK inhibitors and the risk of malignancy : a meta-analysis across disease indications
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Russell, M.
|
Stovin, C.
|
Alveyn, E.
| +10
Wird geladen...
7
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis : the methotrexate monitoring trial
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Hebing, R.
|
Lin, M.
|
Bulatovic Calasan, M.
| +10
Wird geladen...
8
Reducing cardiovascular risk with immunomodulators : a randomised active comparator trial among patients with rheumatoid arthritis
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Solomon, D.
|
Giles, J.
|
Liao, K.
| +51
Wird geladen...
9
Efficacy of synthetic and biological DMARDs : a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Kerschbaumer, A.
|
Sepriano, A.
|
Bergstra, S.
| +14
Wird geladen...
10
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2022 update
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Smolen, J.
|
Landewé, R.
|
Bergstra, S.
| +45
ErratumIn: Ann Rheum Dis. 2023 Mar;82(3):e76. - PMID 36764818
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Filter aufheben
Thema: YL5FZ2Y5U1
Medienart
360
Aufsätze
286
E-Artikel
286
E-Ressourcen
74
Gedruckte Aufsätze
Zeitschriftentitel
360
Annals of the rheumatic diseases
Thema
360
Methotrexate
Research Support, Non-U.S. Gov't
YL5FZ2Y5U1
338
Journal Article
323
Antirheumatic Agents
181
Randomized Controlled Trial
132
Multicenter Study
84
Antibodies, Monoclonal
77
Tumor Necrosis Factor-alpha
74
Antibodies, Monoclonal, Humanized
62
Immunosuppressive Agents
57
Comparative Study
54
B72HH48FLU
54
Infliximab
51
Rheumatoid Arthritis
50
Adalimumab
50
FYS6T7F842
47
Clinical Trial, Phase III
43
Etanercept
43
OP401G7OJC
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
40
2020-
208
2010-2019
89
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
360
Englisch
Haven't found what you're looking for?
Wird geladen...